If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACC.L Regulatory News (ACC)

  • There is currently no data for ACC

Trading Update

18 Jun 2020 07:00

RNS Number : 2923Q
Access Intelligence PLC
18 June 2020
 

Access Intelligence plc

("Access Intelligence" or the "Company")

Trading Update

Access Intelligence (AIM: ACC), the technology innovator delivering Software-as-a-Service ("SaaS") solutions for the PR, communications and marketing industries, announces an update on trading for the six months ended 31 May 2020.

 

The Company's underlying business has performed well through the volatility seen in the first half of the year with strong renewal rates underpinning growth in Annual Contract Value ('ACV') of £1.04m in the period, over double the £0.45m increase for the equivalent period in 2019. This equates to organic annualised ACV growth of 12% and, importantly, all sub brands delivered double digit growth.

 

The Board anticipates total revenue to be £9.4m for the period, a year on year increase of over 50%. Excluding the acquisition of Pulsar, revenue grew by 10%. The Company also implemented a number of cost saving initiatives and the impact of these measures is expected to result in costs being reduced by approximately £1.1m this year. As a result of the comprehensive and rapid response taken by the Company to the COVID-19 disruption, its liquidity position remains strong with net cash of £2.6m at 31 May 2020 compared to £2.0m at 30 November 2019.

 

The Company reacted quickly to establish processes that enabled a successful transition to remote working that protected both the health and safety of staff but also prevented any disruption to client service or product development. The changes were made without impacting the longer-term growth prospects of the business, with cost saving measures including the Company furloughing approximately 15% of staff, salary and fee reductions for the Board and employees for three months, and the curtailment of discretionary spending.

 

Alongside the strong performance in renewal rates the period also saw new business success with clients added including global brands spanning the public, private and charity sectors. New clients wins included Aegon, Allen & Overy, Astra-Zeneca, Chanel, the Co-operative Group, Lotus, Ministry of Justice, Nintendo, OFGEM and the WWF. In the USA, Pulsar won new clients including Dow Jones, the International Monetary Fund, Levi Strauss and Twitter. The wins reflect the improved product portfolio which, since the addition of Pulsar in October 2019, has been strengthened to open up new sectors and international opportunities.

 

The Company continues to actively pursue new business opportunities and remains encouraged by its ongoing pipeline development. Nonetheless COVID-19 has inevitably affected the rate of new business wins as potential new customers put certain projects on hold and delayed investing in new technology products.

 

Given the dynamic nature of the situation it remains hard to predict how our pipeline of opportunities will evolve over the remainder of the year. The uncertainty means that whilst the resilience and strength that the business showed in the first half is very satisfactory and 93% of revenue is recurring, the Company's ability to generate new business in line with our original 2020 expectations remains unclear. Therefore, the Board considers it inappropriate to provide forward-looking guidance until the overall impact of COVID-19 becomes clearer.

 

Christopher Satterthwaite, Non-Executive Chairman of the Company, said: "Despite the challenge COVID-19 has presented all businesses, the last six months trading has demonstrated the strength of the Company with encouraging growth seen across the product portfolio. The strengthening of the portfolio with Pulsar will accelerate growth and by diversifying the product, sector and territorial opportunities, contribute to the Company's overall resilience."

 

 

Enquiries:

Access Intelligence plc

020 3426 4024

Joanna Arnold, CEO

Mark Fautley, CFO

finnCap Limited (Nominated Adviser and Broker)

020 7220 0500

Corporate Finance:

Marc Milmo/Kate Bannatyne/Matthew Radley

 

Corporate Broking:

Alice Lane/Sunila de Silva

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFLFMWESSEEM
Date   Source Headline
24th Jun 20157:00 amRNSCompletion of Acquisition
23rd Jun 201510:36 amRNSHolding(s) in Company
16th Jun 201511:53 amRNSAcquisition, Subscription and Directorate Change
28th May 20153:16 pmRNSResult of AGM
28th May 20151:30 pmRNSStatement re. CMA publication
6th May 20158:00 amRNSPosting of Annual Report and Accounts
30th Apr 20157:00 amRNSFinal Results
21st Apr 20151:00 pmRNSDisposal of Willow Starcom Limited
21st Apr 20151:00 pmRNSAcquisition of Willow Starcom
20th Mar 20157:00 amRNSNotice of Results
9th Dec 20143:58 pmRNSDirector/PDMR Shareholding
8th Dec 20147:00 amRNSIssue of CLNS and Trading Update
1st Sep 201411:53 amRNSFurther re: Acquisition of Solcara Limited
26th Aug 201412:26 pmRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSDirector Dealings
18th Jul 201410:18 amRNSDirector Dealings
16th Jul 20147:00 amRNSInterim Results
28th Apr 201411:51 amRNSResult of AGM
4th Apr 201411:32 amRNSDirector Dealing
1st Apr 20147:00 amRNSPreliminary Results
11th Mar 20147:00 amRNSConvertible Loan Note Extension
23rd Dec 20137:00 amRNSDirector Dealings
19th Dec 20137:00 amRNSTrading Statement and New CLN Terms
25th Oct 20137:00 amRNSGrant of Options
30th Sep 20137:00 amRNSTrading Update
27th Sep 20137:00 amRNSChange of Registered Office
15th Jul 20137:00 amRNSHalf Yearly Report
9th Jul 20139:30 amRNSNotice of Results
31st May 20131:46 pmRNSTotal Voting Rights
20th May 20137:00 amRNSExercise of Options
22nd Apr 20133:29 pmRNSResult of AGM
19th Mar 20137:00 amRNSChange of Adviser Name
6th Mar 20137:00 amRNSChange of Adviser
5th Mar 20137:00 amRNSFinal Results
20th Dec 20127:00 amRNSTrading Update
10th Dec 20127:30 amRNSDirector/PDMR Shareholding
4th Dec 20127:00 amRNSIssue of Equity
18th Jul 20127:00 amRNSHalf Yearly Report
5th Jul 20125:20 pmRNSNotice of Results
16th Apr 20125:34 pmRNSResult of AGM
21st Mar 20129:09 amRNSHolding(s) in Company
13th Mar 20128:59 amRNSDirector Dealing
9th Mar 20127:00 amRNSDirector/PDMR Shareholding
7th Mar 20127:01 amRNSDirectorate Change
7th Mar 20127:00 amRNSFinal Results
19th Dec 20117:00 amRNSTrading Statement
11th Nov 20117:00 amRNSAppointment of Director
3rd Nov 201112:41 pmRNSDirector/PDMR Shareholding
3rd Oct 20111:22 pmRNSRedemption of Loan Notes
23rd Sep 20117:00 amRNSTotal Voting Rights and Directors' Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.